Team:Paris/Addressing overview strategy

From 2009.igem.org

(Difference between revisions)
(→B. Our strategy)
(→Our strategy)
 
(One intermediate revision not shown)
Line 2: Line 2:
{{Template:Paris2009}}
{{Template:Paris2009}}
{{Template:Paris2009_menu3}}
{{Template:Paris2009_menu3}}
-
== Overview ==
+
 
-
* [[Team:Paris/Addressing_overview_exportsystem#Overview |A. Export system ]]
+
 
-
* [[Team:Paris/Addressing_overview_strategy#Overview |B. Our strategy]]
+
==Adressing the message to the cytoplasm : Our strategy==
-
* [[Team:Paris/Addressing_overview_Construction#Overview |C. Construction]]
+
<html>
<html>
 +
<style type="text/css">
 +
#left-side {
 +
    position: absolute;
 +
    height: 23px;
 +
    width: 30px;
 +
    top: 0px;
 +
    left: 150px;
 +
    margin-top:10px;
 +
    padding-top: 7px;
 +
    background: url(https://static.igem.org/mediawiki/2009/1/1b/Left_menu_pari.png);
 +
    z-index:4;
 +
}
 +
 +
#middle-side {
 +
    height: 25px;
 +
    width: 300px;
 +
    position: absolute;
 +
    top: 0px;
 +
    left: 160px;
 +
    margin-top:10px;
 +
    padding-top: 5px;
 +
    background: #dadada;
 +
    z-index:5;
 +
}
 +
 +
#right-side {
 +
    position: absolute;
 +
    height: 23px;
 +
    width: 30px;
 +
    margin-top:10px;
 +
    padding-top: 7px;
 +
    top: 0px;
 +
    left: 440px;
 +
    background: url(https://static.igem.org/mediawiki/2009/4/40/Right_menu_paris.png);
 +
    z-index:4;
 +
}
 +
 +
a.menu_sub {
 +
    padding-left: 7px;
 +
    padding-right: 7px;
 +
}
 +
 +
a.menu_sub_active {
 +
    padding-left: 7px;
 +
    padding-right: 7px;
 +
    color:#b0310e;
 +
    font-weight:bold;
 +
}
 +
</style>
 +
<div id="left-side"></div>
 +
<div id="middle-side"><center>
 +
<a class="menu_sub" href="https://2009.igem.org/Team:Paris/Addressing_overview_exportsystem#bottom"> Export system</a>|
 +
<a class="menu_sub_active"href="https://2009.igem.org/Team:Paris/Addressing_overview_strategy#bottom"> Our Strategy</a>|
 +
<a class="menu_sub"href="https://2009.igem.org/Team:Paris/Addressing_testing#bottom"> Construction</a>
 +
</center>
</div>
</div>
-
<div id="paris_content_boxtop">
+
<div id="right-side"></div>
-
</div>
+
-
<div id="paris_content">
+
</html>
</html>
-
==B. Our strategy==
+
 
We thought of overexpressing the important proteins in the Tat pathway (that is to say TatABCE) in order to avoid the early saturation phenomenon that is likely to occur when we will overexpress proteins that will be targeted to the outer membrane or to the periplasm.
We thought of overexpressing the important proteins in the Tat pathway (that is to say TatABCE) in order to avoid the early saturation phenomenon that is likely to occur when we will overexpress proteins that will be targeted to the outer membrane or to the periplasm.
However, in our strategy, the only protein that needs to use the TAT pathway to translocate from the cytoplasm to the periplasm is clyA. Finally, we decided that the overexpression won't be necessary neither for the TAT pathway, nor for the SEC pathway, both of them constitutively expressed in E Coli K12.
However, in our strategy, the only protein that needs to use the TAT pathway to translocate from the cytoplasm to the periplasm is clyA. Finally, we decided that the overexpression won't be necessary neither for the TAT pathway, nor for the SEC pathway, both of them constitutively expressed in E Coli K12.

Latest revision as of 06:47, 21 October 2009

iGEM > Paris > Adressing > Export systems > Our strategy


Adressing the message to the cytoplasm : Our strategy


We thought of overexpressing the important proteins in the Tat pathway (that is to say TatABCE) in order to avoid the early saturation phenomenon that is likely to occur when we will overexpress proteins that will be targeted to the outer membrane or to the periplasm.

However, in our strategy, the only protein that needs to use the TAT pathway to translocate from the cytoplasm to the periplasm is clyA. Finally, we decided that the overexpression won't be necessary neither for the TAT pathway, nor for the SEC pathway, both of them constitutively expressed in E Coli K12.

Retrieved from "http://2009.igem.org/Team:Paris/Addressing_overview_strategy"